Status:
RECRUITING
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
Lead Sponsor:
Mohammad Daboos
Conditions:
Pediatric Disorder
Esophageal Diseases
Eligibility:
All Genders
2-14 years
Phase:
NA
Brief Summary
This clinical trial study included 21 children with refractory benign esophageal strictures. Upper GI endoscopy performed up to the area of stricture, esophageal dilatation done, endoscopy repeated, a...
Detailed Description
Background and study aims: Benign esophageal strictures are primarily treated with dilation therapy, but strictures can recur or can be unresponsive, requiring additional or repeated treatment. This s...
Eligibility Criteria
Inclusion
- Pediatric patients aged less than 14 years
- with refractory benign esophageal strictures
- received a dilatation therapy without triamcinolone injections
Exclusion
- failure to pass a guide wire secondary to pharyngeal stenosis
- tracheo-esophageal fistula
- those who received triamcinolone injections at early dilatation
Key Trial Info
Start Date :
March 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06514079
Start Date
March 2 2022
End Date
August 20 2024
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammad Daboos
Cairo, Select, Egypt, 115678